Chinese Bidder Draws Closer To Complete Genomics Buy
After Chinese officials signed off Friday on Chinese company's bid for California-based gene sequencer Complete Genomics Inc., all eyes are on a Delaware court, where shareholder litigation continues, and on rival Illumina...To view the full article, register now.
Already a subscriber? Click here to view full article